Xenoport to be acquired

Arbor Pharmaceuticals will acquire Xenoport Inc. (Nasdaq: XNPT) for a premium of approximately $467 million in cash. The stock price leaped $2.49 to $6.89.


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.